Chi­na bans GSK from drug pro­cure­ment ac­tiv­i­ties through April 2024

Fol­low­ing an in­spec­tion of GSK’s CD­MO Poz­nan, Poland-based site that iden­ti­fied ques­tion­able prac­tices, Chi­na has de­cid­ed to ban the com­pa­ny from par­tic­i­pat­ing in its cen­tral­ized …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER